Y Intercept (Hong Kong) LTD Takeda Pharmaceutical CO LTD Transaction History

Y Intercept (Hong Kong) LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$15.28 - $16.48 $225,762 - $243,492	14,775 Added 46.88%	46,294 $762,000
Q4 2022 Feb 14, 2023	BUY	$12.42 - $15.62 $391,465 - $492,326	31,519 New	31,519 $492,000
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $269,703 - $305,756	-19,919 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $262,333 - $326,671	19,919 New	19,919 $271,000
Q2 2021 Aug 12, 2021	SELL	$16.55 - $18.64 $574,003 - $646,491	-34,683 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$16.71 - $19.9 $579,552 - $690,191	34,683 New	34,683 $636,000

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.